Mechanism-based inactivator of isocitrate lyases 1 and 2 from Mycobacterium tuberculosis
- Texas A & M Univ., College Station, TX (United States)
- Univ. at Buffalo, The State Univ. of New York, Buffalo, NY (United States)
- Univ. at Buffalo, The State Univ. of New York, Buffalo, NY (United States); Janssen Research and Development, Malvern, PA (United States)
- Victoria Univ. of Wellington (New Zealand)
- Texas A & M Univ., College Station, TX (United States); Fujifilm Diosynth Biotechnologies Texas, College Station, TX (United States)
- Texas A & M Univ., College Station, TX (United States); Albany Molecular Research, Inc., Albany, NY (United States)
Isocitrate lyase (ICL, types 1 and 2) is the first enzyme of the glyoxylate shunt, an essential pathway for Mycobacterium tuberculosis (Mtb) during the persistent phase of human TB infection. Here, we report 2-vinyl-d-isocitrate (2-VIC) as a mechanism-based inactivator of Mtb ICL1 and ICL2. The enzyme-catalyzed retro-aldol cleavage of 2-VIC unmasks a Michael substrate, 2-vinylglyoxylate, which then forms a slowly reversible, covalent adduct with the thiolate form of active-site Cys191. 2-VIC displayed kinetic properties consistent with covalent, mechanism-based inactivation of ICL1 and ICL2 with high efficiency (partition ratio, <1). As a result, analysis of a complex of ICL1:2-VIC by electrospray ionization mass spectrometry and X-ray crystallography confirmed the formation of the predicted covalent S-homopyruvoyl adduct of the active-site Cys191.
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- National Institutes of Health (NIH); Welch Foundation
- Grant/Contract Number:
- P011AI095208; A-0015
- OSTI ID:
- 1390888
- Journal Information:
- Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Issue 29; ISSN 0027-8424
- Publisher:
- National Academy of SciencesCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Web of Science
Erratum: Mechanistic enzymology in drug discovery: a fresh perspective
|
journal | December 2017 |
Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2
|
journal | October 2019 |
Mechanistic enzymology in drug discovery: a fresh perspective
|
journal | December 2017 |
Similar Records
In vitro incorporation of label from (. gamma. /sup 32/P) ATP into isocitrate lyase of Escherichia coli
Substrate-decreased modification by diethyl pyrocarbonate of two histidines in isocitrate lyase from Escherichia coli